“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business. 

Those include the nation’s most populace state, which employs 1,700 members of the specialty earning $339,140 annually. 

New research, presented at SNMMI 2023, details how the brains of obese individuals differ from those who maintain a healthy weight.  

The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far. 

Cleveland Clinic scientists believe their research findings could have “broad and far reaching” implications for the specialty. 

The Germany-based corporation said this is the “only contrast agent approved for this indication” in America. 

“We must not lose momentum," ACR, the Academy for Radiology & Biomedical Imaging Research and more than 100 other organizations wrote to leaders of the U.S. Senate. 

Americans are somewhat more troubled than thrilled over AI’s mounting presence in modern life. But the collective outlook is a rich blend of both.

Buzzworthy developments of the past few days.

"The FDA's approval of colchicine confirms that we are entering a new era of patient care," said one veteran cardiologist familiar with the drug.